Religa, Dorota

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 263

Mortality Risk after Dementia Diagnosis by Dementia Type and Underlying Factors: A Cohort of 15,209 Patients based on the Swedish Dementia Registry

Garcia-Ptacek, S., Farahmand, B., Kåreholt, I., Religa, D., Cuadrado, M. L., & Eriksdotter, M. (2014) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchPalliative Care and End-of-Life Issues

Cited by 176

EFNS ‐ ENS / EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

Schmidt, R., Hofer, E., Bouwman, F. H., Buerger, K., Cordonnier, C., Fladby, T., Galimberti, D., Georges, J., Heneka, M. T., Hort, J., et al. (2015) · European Journal of Neurology

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 140

Dental care utilization in patients with different types of dementia: a longitudinal nationwide study of 58,037 individuals

Fereshtehnejad, S., Garcia‐Ptacek, S., Religa, D., Holmer, J., Buhlin, K., Eriksdotter, M., & Sandborgh‐Englund, G. (2018) · Alzheimer's & Dementia

Dental Health and Care UtilizationDementia and Cognitive Impairment Research

Cited by 81

Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study

Tang, B., Sjölander, A., Wastesson, J. W., Maura, G., Blotiere, P.-O., Szilcz, M., Mak, J. K. L., Qin, C., Alvarsson, M., Religa, D., et al. (2024) · eClinicalMedicine

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 57

Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry

Enache, D., Fereshtehnejad, S. ‐., Kåreholt, I., Cermakova, P., Garcia‐Ptacek, S., Johnell, K., Religa, D., Jelic, V., Winblad, B., Ballard, C., et al. (2016) · Acta Psychiatrica Scandinavica

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 42

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)

Fereshtehnejad, S.-M., Religa, D., Westman, Lökk, J., Eriksdotter, M., & Aarsland, D. (2013) · Neuropsychiatric Disease and Treatment

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 42